CellGenix® rh TGF-β1 (Preclinical Grade)

Top Features for Recombinant Transforming Growth Factor-beta 1:

  • Optimal use of expansion of HSC's
  • ADCF Level 2
  • High purity to ensure the safety of your process
  • Available in two different grades (Preclinical and GMP grade)

Preclinical grade:

  • Intended for preclinical ex vivo use
  • Endotoxin Level ≤ 10 EU/mg
  • GMP transferable: Seamless transition from preclinical development to commercial manufacturing

GMP grade:

  • Intended for clinical ex vivo use
  • Endotoxin Level ≤ 10 EU/mg
  • Manufactured in accordance with applicable GMP guidelines
  • FDA Drug Master File (DMF) available
  • Technical and regulatory support available

Application
Quantity Price per unit
0-9 $1,040.00
10+ $832.00
Item No.: 
1426-050

Letter of Authorization (LOA)

Place a request for a Letter of Authorization (LOA) for our Drug Master File (FDA)

CellGenix® rh Cytokines - Preclinical vs GMP

Both product grades are produced under the same conditions in a GMP facility, ensuring an equal product quality and performance. We offer a more comprehensive QC testing including tighter specifications and documentation for our GMP products: CellGenix® rh Cytokines - Preclinical vs GMP

"

CellGenix® Preclinical Recombinant Human Transforming Growth Factor-beta 1 (TGF-β1) is an animal-derived component-free product. It is produced in a dedicated animal-free GMP facility.

TGF-β1 is used in the cell and gene therapy space to promote expansion of induced pluripotent stem cells (iPSCs), embryonic stem cells (ESCs), mesenchymal stem cells (MSCs) and regulatory T cells (Tregs). CellGenix® Recombinant Human TGF-β1 is produced using a human amniocyte cell line (CAP®) to enable authentic human post-translational modifications.

CAP® is a registered trademark of CEVEC Pharmaceuticals GmbH, Germany.

Designed to meet the demands of translational research, CellGenix® preclinical cytokines are ideal to bridge the gap between the lower quality of research grade and the high cost of GMP grade materials.

Please access the Certificate of Analysis on the My Sartorius Portal.

Expiry: 3 years from date of shipping

"

icon-article

Tech Note:

ADCF and Serum-free Policy

Download Now
icon-article

Tech Note:

Shipment at Ambient Temperatures

Download Now
icon-approval

Certificate of Analysis:

Download on the My Sartorius portal

My Sartorius
icon-article

Tech Note:

Quality TGF-β1

Download Now
icon-article

Tech Note:

Stability of GMP Cytokines after Reconstitution 

Download Now
icon-article

Tech Note:

Batch-to-Batch Consistency of CellGenix® GMP Cytokines

Download Now

Applications

  • Application
    Preclinical ex vivo use
  • Application Area
    • Cell & gene therapy
    • Immunology
  • Cell Type
    • MSC
    • T Cells
    • ESC/iPSC
    • Organoids

Biological Information

  • Activity
    ≥ 9 x 106 IU/mg

Compliance Information

  • Origin
    Animal-Component Free

Features

  • Carrier-Protein Free
    Yes

Physicochemical Information

  • Endotoxin
    ≤ 1 EU/µg
  • Expression System
    CAP® cell line
  • Formulation
    Lyophilized from a 0.2 µm-filtered solution containing 1% mannitol

Product Information

  • Brand
    CellGenix®
  • Package Type
    Vial
  • Size
    50 µg

Sterility/Purity

  • Delivery Condition
    Sterile
  • Purity
    ≥ 95%

Weight

  • Molecular Weight (kDa)
    25.6 kDa